Perfil
Seth Salpeter is the Chief Technology Officer and founder of Curesponse Ltd.
founded in 2017.
Dr. Salpeter is also the founder of Immunyx Pharma Ltd.
Cargos activos de Seth Salpeter
| Empresas | Cargo | Inicio |
|---|---|---|
Curesponse Ltd.
 Curesponse Ltd. Packaged SoftwareTechnology Services Curesponse Ltd. develops a technology to improve cancer research and drug diagnostics. Its services include personalized cancer treatment regimen. The company was founded by Guy Neev, Seth Salpeter, and Ravid Straussman on November 5, 2017 and is headquartered in Tel Aviv, Israel. | Fundador | 05/11/2017 |
Immunyx Pharma Ltd.
 Immunyx Pharma Ltd. Pharmaceuticals: GenericHealth Technology Immunyx Pharma Ltd. is based in New York, NY. Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Immunyx Pharma Ltd. was founded by Seth Salpeter, Zvi Fridlender, and Zvika Granot. Seth Salpeter has been the CEO since incorporation. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Curesponse Ltd.
Curesponse Ltd. Packaged SoftwareTechnology Services Curesponse Ltd. develops a technology to improve cancer research and drug diagnostics. Its services include personalized cancer treatment regimen. The company was founded by Guy Neev, Seth Salpeter, and Ravid Straussman on November 5, 2017 and is headquartered in Tel Aviv, Israel. | Technology Services |
Immunyx Pharma Ltd.
Immunyx Pharma Ltd. Pharmaceuticals: GenericHealth Technology Immunyx Pharma Ltd. is based in New York, NY. Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Immunyx Pharma Ltd. was founded by Seth Salpeter, Zvi Fridlender, and Zvika Granot. Seth Salpeter has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Seth Salpeter
